SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 66 filers reported holding SOLENO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 43 | -86.6% | 0.00% | – |
| Q4 2021 | $0 | – | 322 | -45.8% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 594 | -94.4% | 0.00% | – |
| Q2 2021 | $12,000 | – | 10,653 | +3167.8% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 326 | -99.3% | 0.00% | – |
| Q4 2020 | $85,000 | +286.4% | 44,128 | +411.7% | 0.00% | – |
| Q3 2020 | $22,000 | -37.1% | 8,624 | -44.7% | 0.00% | – |
| Q2 2020 | $35,000 | +3400.0% | 15,581 | +3775.9% | 0.00% | – |
| Q1 2020 | $1,000 | – | 402 | +474.3% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 70 | -87.4% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 555 | +0.9% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 550 | -34.4% | 0.00% | – |
| Q1 2019 | $2,000 | – | 839 | +3895.2% | 0.00% | – |
| Q4 2018 | $0 | – | 21 | -85.5% | 0.00% | – |
| Q4 2017 | $0 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $9,500,000 | 2.16% |
| Nantahala Capital Management | 9,765,129 | $9,028,000 | 0.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $1,971,000 | 0.24% |
| Granite Point Capital Management, L.P. | 701,838 | $649,000 | 0.05% |
| OPPENHEIMER & CO INC | 639,140 | $591,000 | 0.01% |
| Ikarian Capital, LLC | 121,694 | $112,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $28,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $9,000 | 0.01% |
| Ergoteles LLC | 74,525 | $69,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 744,000 | $688,000 | 0.00% |